Hydroxychlorodenafil
Hydroxychlorodenafil (compound 40) is a phosphodiesterase (PDE) inhibitor. Hydroxychlorodenafil can be used in cancer research[1].
Product Specifications
CAS Number
1391054-00-4
UNSPSC
12352005
Target
Phosphodiesterase (PDE)
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/hydroxychlorodenafil.html
Smiles
O=C1C(N(C)N=C2CCC)=C2N=C(C3=CC(C(O)CCl)=CC=C3OCC)N1
Molecular Formula
C19H23ClN4O3
Molecular Weight
390.86
References & Citations
[1]Xiang Fei, et al. Use of a composition comprising a heterocyclic compound for the manufacture of a medicament for the treatment of phosphodiesterase mediated diseases. 2020.04.05.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC400809-500 1x 500 µL
Cyclin D1 (CCND1/809), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC941912-100 1x 100 µL
ROR2 (ROR2/1912), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 